- Home
- LXP vs QDEL Comparison
LXP vs QDEL Comparison
Compare LXP & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXP
- QDEL
- Stock Information
- Founded
- LXP 1993
- QDEL 1979
- Country
- LXP United States
- QDEL United States
- Employees
- LXP N/A
- QDEL N/A
- Industry
- LXP Real Estate Investment Trusts
- QDEL Medical Specialities
- Sector
- LXP Real Estate
- QDEL Health Care
- Exchange
- LXP Nasdaq
- QDEL Nasdaq
- Market Cap
- LXP 2.6B
- QDEL 2.1B
- IPO Year
- LXP 1993
- QDEL N/A
- Fundamental
- Price
- LXP $9.54
- QDEL $30.61
- Analyst Decision
- LXP Hold
- QDEL Hold
- Analyst Count
- LXP 3
- QDEL 6
- Target Price
- LXP $10.50
- QDEL $39.00
- AVG Volume (30 Days)
- LXP 3.7M
- QDEL 1.3M
- Earning Date
- LXP 10-30-2025
- QDEL 11-05-2025
- Dividend Yield
- LXP 5.65%
- QDEL N/A
- EPS Growth
- LXP 203.57
- QDEL N/A
- EPS
- LXP 0.27
- QDEL N/A
- Revenue
- LXP $363,003,000.00
- QDEL $2,741,600,000.00
- Revenue This Year
- LXP N/A
- QDEL N/A
- Revenue Next Year
- LXP $5.19
- QDEL $2.65
- P/E Ratio
- LXP $35.37
- QDEL N/A
- Revenue Growth
- LXP 6.63
- QDEL N/A
- 52 Week Low
- LXP $6.85
- QDEL $22.05
- 52 Week High
- LXP $9.95
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- LXP 60.64
- QDEL 62.32
- Support Level
- LXP $9.42
- QDEL $25.48
- Resistance Level
- LXP $9.79
- QDEL $30.85
- Average True Range (ATR)
- LXP 0.21
- QDEL 1.21
- MACD
- LXP 0.03
- QDEL 0.25
- Stochastic Oscillator
- LXP 76.20
- QDEL 98.32
About LXP LXP Industrial Trust (Maryland REIT)
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.